Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ponatinib or Blinatumomab in Ph+ ALL (EWALL-Ph-03)
NCT04688983Phase 2Not yet recruiting
- Sponsor
- Cardiff University
- Start
- Jan 2021
- Primary completion
- Jan 2024
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of ponatinib in acute lymphoblastic leukemia (ALL), sponsored by Cardiff University. Planned start Jan 2021; status: not yet recruiting.
02
Drugs
ponatinib
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT04688983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04688983.